Biosimilars Pipeline
Oncology, Autoimmune Diseases
Key Facts
About Laurus Labs
Laurus Labs is a vertically integrated pharmaceutical company based in Hyderabad, India, with a significant global presence in the API and generic formulations market. It has established itself as a key player in the global supply of HIV/AIDS drugs and has strategically expanded into high-growth areas like oncology, cardiology, and diabetes. The company leverages its strong R&D and manufacturing capabilities to serve both regulated and emerging markets, with a growing CDMO business catering to innovator companies worldwide.
View full company profileAbout Amphastar Pharmaceuticals
Amphastar Pharmaceuticals is a vertically integrated biopharmaceutical company with a core mission to develop and deliver high-quality, complex generic and proprietary injectable, inhalation, and intranasal medications. The company has established a strong commercial footprint with products like BAQSIMI®, the leading prescribed glucagon in the U.S., and has been recognized by the FDA for its efforts in alleviating critical drug shortages. Its strategic direction leverages proprietary technological platforms to advance a pipeline of biosimilars and innovative drug delivery systems, aiming to provide accessible treatments across therapeutic areas such as diabetes, respiratory diseases, and anemia.
View full company profileTherapeutic Areas
Other Oncology, Autoimmune Diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| Novel Monoclonal Antibodies | Changchun High-Tech Industry | Pre-clinical |
| Biosimilar (Rituximab) | Ipca Laboratories | Development |
| Biosimilar Candidates | China Resources Pharmaceutical Group | Phase 3 |
| Biosimilars (e.g., trastuzumab, rituximab) | Aspen Pharmacare | Approved |
| Biosimilar Pipeline (Confidential) | Gland Pharma | Development |